| Patients |
Age/Sex |
VA at Presentation |
VA
at 1 month |
VA
at 6 months |
Symptoms to presentation duration |
Residual macular scar |
| 1 |
38/F |
CF 1F |
20/30 |
20/30 |
1 week |
Yes |
| 2 |
54/M |
CF 5F |
20/200 |
20/60 |
20 days |
Yes |
| 3 |
45/F |
20/40 |
20/25 |
20/25 |
6 days |
Yes |
| 4 |
27/M |
20/400 |
20/35 |
20/35 |
2 weeks |
Yes |
| 5 |
16//M |
CF 3F |
CF 5F |
20/400 |
3 weeks |
Yes |
| 6 |
50/M |
CF 2F |
20/30 |
20/40 |
5 weeks |
Yes |
| 7 |
50/M |
CF 2F |
20/60 |
20/30 |
9 days |
Yes |
| 8 |
38/F |
CF 2F |
20/200 |
20/25 |
15 days |
Yes |
| 9 |
18/F |
20/120 |
20/50 |
20/25 |
5 days |
Yes |
| 10 |
42/M |
CFNF |
20/400 |
20/400 |
6 weeks |
Yes |
| 11 |
16/M |
20/200 |
20/20 |
20/20 |
9 hours |
No |
| 12 |
25/M |
CF3F |
20/25 |
20/16 |
14 hours |
No |
|
| VA: Visual Acuity; CF: Counting Fingers; CFN: Counting Fingers Near Face; F: Foot/Feet. |
| Table 1: Twelve patients with macular toxoplasmosis before and after
treatment. |
